SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
Feb 18, 2021
Document Date
Feb 16, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Akebia Therapeutics
Issuer
Akebia Therapeutics, Inc.
Filer
ZUMWALT LEANNE M
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet
Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142
+1 617.871.2098 phone
+1 617.871.2099 fax